These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22994709)

  • 1. Linear and conformational B cell epitope prediction of the HER 2 ECD-subdomain III by in silico methods.
    Mahdavi M; Mohabatkar H; Keyhanfar M; Dehkordi AJ; Rabbani M
    Asian Pac J Cancer Prev; 2012; 13(7):3053-9. PubMed ID: 22994709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
    Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
    Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a novel chimeric peptide representing B and T cell epitopes from HER2 extracellular domain (HER2 ECD) for breast cancer.
    Mahdavi M; Keyhanfar M; Jafarian A; Mohabatkar H; Rabbani M
    Tumour Biol; 2014 Dec; 35(12):12049-57. PubMed ID: 25142233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of B cell epitopes of the extracellular domain of insulin-like growth factor-1 receptor.
    Bayrami V; Keyhanfar M; Mohabatkar H; Mahdavi M; Moreau V
    Mol Biol Res Commun; 2016 Dec; 5(4):201-214. PubMed ID: 28261624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes.
    Deng X; Zheng X; Yang H; Moreira JM; Brünner N; Christensen H
    PLoS One; 2014; 9(9):e106448. PubMed ID: 25192037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
    Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
    Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope Mapping of Human HER2 Specific Mouse Monoclonal Antibodies Using Recombinant Extracellular Subdomains.
    Hosseini Ghatar R; Soltantoyeh T; Bahadori T; Golara M; Hassannia H; Khosravi Eghbal R; Khoshnoodi J; Judaki MA; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F
    Asian Pac J Cancer Prev; 2017 Nov; 18(11):3103-3110. PubMed ID: 29172286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell epitopes of antigenic proteins in Leishmania infantum: an in silico analysis.
    Assis LM; Sousa JR; Pinto NF; Silva AA; Vaz AF; Andrade PP; Carvalho EM; De Melo MA
    Parasite Immunol; 2014 Jul; 36(7):313-23. PubMed ID: 24606067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and Characterization of New Anti-HER2 Monoclonal Antibodies.
    Mahdavi M; Keyhanfar M; Jafarian A; Mohabatkar H; Rabbani M
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):213-21. PubMed ID: 26090600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein.
    Orlandi R; Formantici C; Ménard S; Boyer CM; Wiener JR; Colnaghi M
    Biol Chem; 1997 Nov; 378(11):1387-92. PubMed ID: 9426199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of linear B-cell epitopes.
    Reimer U
    Methods Mol Biol; 2009; 524():335-44. PubMed ID: 19377956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro.
    Hosseini Ghatar R; Soltantoyeh T; Bahadori M; Khoshnoodi J; Golsaz Shirazi F; Jeddi Tehrani M; Amiri MM; Shokri F
    Iran J Immunol; 2017 Sep; 14(3):200-214. PubMed ID: 28919583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu.
    Garrett JT; Rawale S; Allen SD; Phillips G; Forni G; Morris JC; Kaumaya PT
    J Immunol; 2007 Jun; 178(11):7120-31. PubMed ID: 17513761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics and immunologic investigation on B and T cell epitopes of Cur l 3, a major allergen of Curvularia lunata.
    Sharma V; Singh BP; Gaur SN; Pasha S; Arora N
    J Proteome Res; 2009 Jun; 8(6):2650-5. PubMed ID: 19290623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.
    Dakappagari NK; Lute KD; Rawale S; Steele JT; Allen SD; Phillips G; Reilly RT; Kaumaya PT
    J Biol Chem; 2005 Jan; 280(1):54-63. PubMed ID: 15507452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond B-Cell Epitopes: Curating Positive Data on Antipeptide Paratope Binding to Support Peptide-Based Vaccine Design.
    Caoili SEC
    Protein Pept Lett; 2021; 28(8):953-962. PubMed ID: 33602065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).
    Gabrielli F; Salvi R; Garulli C; Kalogris C; Arima S; Tardella L; Monaci P; Pupa SM; Tagliabue E; Montani M; Quaglino E; Stramucci L; Curcio C; Marchini C; Amici A
    PLoS One; 2013; 8(3):e58358. PubMed ID: 23555577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development.
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2007; 8(1):137-8. PubMed ID: 17477789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies.
    Rockberg J; Schwenk JM; Uhlén M
    Mol Oncol; 2009 Jun; 3(3):238-47. PubMed ID: 19393584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.